Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models

BACKGROUND: The phase 3 trial of the RTS,S/AS01 malaria vaccine candidate showed modest efficacy of the vaccine against Plasmodium falciparum malaria, but was not powered to assess mortality endpoints. Impact projections and cost-effectiveness estimates for longer timeframes than the trial follow-up...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Lancet
Autors principals: Penny, Melissa A, Verity, Robert, Bever, Caitlin A, Sauboin, Christophe, Galactionova, Katya, Flasche, Stefan, White, Michael T, Wenger, Edward A, Van de Velde, Nicolas, Pemberton-Ross, Peter, Griffin, Jamie T, Smith, Thomas A, Eckhoff, Philip A, Muhib, Farzana, Jit, Mark, Ghani, Azra C
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2016
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4723722/
https://ncbi.nlm.nih.gov/pubmed/26549466
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(15)00725-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars